Research paper
Lymphocyte adhesion to brain capillary endothelial cells in vitro

https://doi.org/10.1016/0165-5728(94)90155-4Get rights and content

Abstract

The presence and upregulation of adhesion molecules on bovine brain endothelial cells (BBEC) were investigated. Monolayers of BBEC were incubated with lipopolysaccharide (LPS), interleukin-1β (rhIL-1β), and interleukin-6 (rhIL-6) to simulate in vitro an inflammatory site in the cerebral capillaries. Adhesion of lymphocytes to BBEC increased 4.1-fold after stimulation of the endothelial cells for 4 h with 5 or 10 ng/ml LPS. Lymphocyte adhesion increased after incubation of the BBEC for 4 h with IL-1 and was increased 3.7-fold using 100 ng/ml IL-1. BBEC pre-incubated with IL-6 for 4 h also showed an increase in adhesion of lymphocytes, and cells pretreated with 100 ng/ml IL-6 showed a 3-fold increase in lymphocyte adherence. Specific monoclonal antibodies directed against CD11a, CD18, and VLA-4 were able to block adherence of lymphocytes to stimulated BBEC. These results indicate that the in vitro activation of BBEC may serve as a model for the study of inflammation of the blood-brain barrier.

References (30)

  • K.L. Audus et al.

    Characterization of an in vitro model for studying drug transport and metabolism

    Pharmacol. Res.

    (1986)
  • M.W.B. Bradbury

    The blood-brain barrier: transport across the cerebral endothelium

    Circ. Res.

    (1985)
  • H.E. De Vries et al.

    Characterization of the scavenger receptor on cerebral endothelial cells in vitro

    J. Neurochem.

    (1993)
  • A.S.M. Dofferhof et al.

    Tumour necrosis factor (cachectin) and other cytokines in septic shock: a review of the literature

    Neth. J. Med.

    (1991)
  • M.L. Dustin et al.

    Lymphocyte function associated antigen LFA-1 interaction with intracellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells

    J. Cell Biol.

    (1988)
  • Cited by (42)

    • Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management

      2011, European Journal of Pharmacology
      Citation Excerpt :

      LPS can increase blood-brain barrier permeability through many different pathways (Jaeger et al., 2009; Wispelwey et al., 1988; Xaio et al., 2001) (Fig. 1: pathway 5). It can enhance endocytosis by brain endothelial cells (Banks et al., 1999) and facilitate immune cell trafficking (de Vries et al., 1994; Persidsky et al., 1997). Furthermore, LPS can stimulate brain endothelial cells to secrete cytokines (Reyes et al., 1999; Verma et al., 2006).

    • The blood-brain barrier and immune function and dysfunction

      2010, Neurobiology of Disease
      Citation Excerpt :

      The human immunodeficiency virus and its surface coat glycoprotein gp120 can enter the brain by this mechanism and LPS enhances the transport of both of them across the BBB (Dohgu and Banks, 2008). Immune cell adhesion and trafficking are enhanced by LPS (De Vries et al., 1994; Persidsky et al., 1997). Several saturable transport systems, including those for insulin and cisplatin, are increased whereas others, including that of tumor necrosis factor-alpha, are not (Banks et al., 2008; Minami et al., 1998; Osburg et al., 2002).

    • Lipopolysaccharide alters the blood-brain barrier transport of amyloid β protein: A mechanism for inflammation in the progression of Alzheimer's disease

      2009, Brain, Behavior, and Immunity
      Citation Excerpt :

      One circulating factor that could be acting at the BBB to alter I-Aβ transport is LPS itself. LPS can act directly on brain endothelial cells to induce release of cytokines and to increase lymphocyte adhesion (De Vries et al., 1994; Verma et al., 2006). We tested a series of concentrations of LPS in an in vitro monolayer model, with the highest dose of LPS disrupting the monolayer model as shown by a decrease in TEER.

    • Leptin, Insulin and Blood-Brain Barrier Relations in Obesity

      2005, The Metabolic Syndrome at the Beginning of the XXI Century: A Genetic and Molecular Approach
    • Mononuclear Phagocytes at the Blood-Brain Barrier in Multiple Sclerosis

      2004, Blood-Spinal Cord and Brain Barriers in Health and Disease
    View all citing articles on Scopus
    ∗∗

    Phone (071) 276240; Fax (071) 276292

    View full text